🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase Ib/II trial tests the safety, side effects, best dose and how we...
Status
Recruiting
Location
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
Start Date
2026-10-13
Trial ID
NCT07069699
CX5461 is a new type of drug for many types of cancer, particularly cancers...
Status
Completed
Location
BCCA - Vancouver Cancer Centre
Start Date
2016-06-13
Trial ID
NCT02719977
Treatments Being Tested
This is an open-label, multi-center, phase 1b study designed to determine a...
Status
Recruiting
Location
University of California, Los Angeles
Start Date
2021-09-08
Trial ID
NCT04890613
Treatments Being Tested
This phase I trial tests the safety, side effects, and best dose of pidnaru...
Status
Recruiting
Location
Dana-Farber Cancer Institute
Start Date
2026-10-05
Trial ID
NCT07137416
This phase I trial tests the safety, side effects, and best dose of pidnaru...
Status
Recruiting
Location
National Cancer Institute Developmental Therapeutics Clinic
Start Date
2025-07-01
Trial ID
NCT06606990
This is phase I, open label, multicentre, dose-escalation study where both ...
Status
Suspended
Location
St Vincent's Hospital Sydney
Start Date
2022-10-21
Trial ID
NCT05425862
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of pidnarulex ...
Status
Recruiting
Location
MedStar Georgetown University Hospital
Start Date
2026-08-10
Trial ID
NCT07147231